Anthrax Treatment Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Integrated Bio Therapeutics Inc.
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Zydus Group
- GC Biopharma, corp.
- BlueWillow Biologics.
- Emergent BioSolutions
- ARISTO Pharmaceuticals Private Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of anthrax treatment is evaluated at USD 460.98 million.
The global anthrax treatment market size was worth over USD 433.29 million in 2025 and is poised to witness a CAGR of over 7.1%, crossing USD 860.35 million revenue by 2035.
North America anthrax treatment market will secure over 35% share, driven by rising spending in healthcare and increased awareness of health threats, forecast period 2026–2035.
Key players in the market include Integrated Bio Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Bayer AG, Zydus Group, GC Biopharma, corp., BlueWillow Biologics., ARISTO Pharmaceuticals Private Limited, Takeda Pharmaceutical Company Limited.
